|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis显示文摘 | Ana-Carolina Cardoso Rami Moucari Claudio Figueiredo-Mendes Marie-Pierre Ripault Nathalie Giuily Corinne Castelnau Nathalie Boyer Tarik Asselah Michelle Martinot-Peignoux Sarah Maylin Roberto J. Carvalho-Filho Dominique Valla Pierre Bedossa Patrick Marcel | 2010 | Journal of Hepatology2010，，5： | 3 |
| 2 | <ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘 | Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick | 2008 | Gastroenterology2008，，2： | 2 |
| 3 | High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study显示文摘 | Rami Moucari Anneke Korevaar Olivier Lada Michelle Martinot-Peignoux Nathalie Boyer Vincent Mackiewicz Agnes Dauvergne Ana C. Cardoso Tarik Asselah Marie-Hélène Nicolas-Chanoine Michel Vidaud Dominique Valla Pierre Bedossa Patrick Marcellin | 2009 | Journal of Hepatology2009，，6： | 2 |
| 4 | Impact of ribavirin dose on retreatment of chronic hepatitis C patients显示文摘AIM: To study the efficacy and factors associated with a sustained virological response (SVR) in chronic hepatitis C (CHC) relapsing patients. METHODS: Out of 1228 CHC patients treated with pegylated interferon (PEG-IFN) and ribavirin (RBV), 165 (13%) had a relapse. Among these, 62 patients were retreated with PEG-IFN-2a or-2b and RBV. Clinical, biological, virological and histological data were collected. Initial doses and treatment modifications were recorded. The efficacy of retreatment and predictive factors for SVR were analyzed. RESULTS: An SVR was achieved in 42% of patients. SVR was higher in young (< 50 years) (61%) than old patients (27%) (P = 0.007), and in genotype 2 or 3 (57%) than in genotype 1 or 4 (28%) patients (P = 0.023). Prolonging therapy for at least 24 wk more than the previous course was associated with higher SVR rates (53% vs 28%, P = 0.04). Also, a better SVR rate was observed with RBV dose/body weight > 15.2 mg/kg per day (70% vs 35%, P = 0.04). In logistic regression, predictors of a response were age (P = 0.018), genotype (P = 0.048) and initial RBV dose/body weight (P = 0.022). None of the patients without a complete early virological response achieved an SVR (negative predictive value = 100%). CONCLUSION: Retreatment with PEG-IFN/RBV is effective in genotype 2 or 3 relapsers, especially in young patients. A high dose of RBV seems to be important for the retreatment response. | Christiane Stern Michelle Martinot-Peignoux Marie Pierre Ripault Nathalie Boyer Corinne Castelnau Dominique Valla Patrick Marcellin | 2012 | World Journal of Gastroenterology2012，18，23： | 1 |
| 5 | <ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘 | Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick | 2008 | Gastroenterology2008，，2： | 1 |
| 6 | Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘 | Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick | 2008 | Gastroenterology2008，，2： | 1 |
| 7 | IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C显示文摘 | Tarik Asselah Simon De Muynck Philippe Bro?t Julien Masliah-Planchon Maud Blanluet Ivan Bièche Martine Lapalus Michelle Martinot-Peignoux Olivier Lada Emilie Estrabaud Qian Zhang Ahmed El Ray Dominique Vidaud Marie-Pierre Ripault Nathalie Boyer Pierre Bed | 2011 | Journal of Hepatology2011，，3： | 1 |
| 8 | Diabetes mellitus is an independent prognostic factor for major liver‐related outcomes in patients with cirrhosis and chronic hepatitis C显示文摘 | Laure Elkrief Pascale Chouinard Noelle Bendersky David Hajage Béatrice Larroque Gérard Babany Blaise Kutala Claire Francoz Nathalie Boyer Richard Moreau Fran?ois Durand Patrick Marcellin Pierre‐Emmanuel Rautou Dominique Valla | 2014 | Hepatology2014，，3： | 1 |
| 9 | Regulatory Capture md Banking Supervision Reform显示文摘 | Pierre C Boyer Jorge Poncev | 2012 | Journal of Fi- laneial Stability2012，8，3： | 1 |
| 10 | Potential of SAR sensors TerraSAR-X, ASAR/ENVISAT and PALSAR/ALOS for monitoring sugarcane crops on Reunion Island显示文摘 | Nicolas Baghdadi Nathalie Boyer Pierre Todoroff Mahmoud El Hajj Agnès Bégué | 2009 | Remote Sensing of Environment2009，，8： | 1 |
| 11 | Spiral CT quantification of aorto-renal calcification and its use in the detection of atheromatous renal artery stenosis: A study in 42 patients显示文摘 | Pierre Gayard Jean-Marc Garcier Jean-Yves Boire Anne Ravel Nessim Perez Christian Privat Pascal Lucien Jean-Fran?ois Viallet Louis Boyer | 2000 | Cardiovascular and Interventional Radiology2000，，1： | 1 |
| 12 | Influence of unclogging agents on the surface state of enteral feeding tubes显示文摘 | Pierre - Adelin Rucart Anne Boyer - Grand | 2011 | 35(2)255 - 2632011，35，2： | 1 |
| 13 | Serum Proteome to Predict Virologic Response in Patients With Hepatitis C Treated by Pegylated Interferon Plus Ribavirin显示文摘 | Valérie Paradis Tarik Asselah Delphine Dargere Marie–Pierre Ripault Michèle Martinot Nathalie Boyer Dominique Valla Patrick Marcellin Pierre Bedossa | 2006 | Gastroenterology2006，，7： | 1 |
| 14 | Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa‐2a in HBeAg‐negative patients显示文摘 | Rami Moucari Vincent Mackiewicz Olivier Lada Marie‐Pierre Ripault Corinne Castelnau Michelle Martinot‐Peignoux Agnes Dauvergne Tarik Asselah Nathalie Boyer Pierre Bedossa Dominique Valla Michel Vidaud Marie‐Hélène Nicolas‐Chanoine Patrick Marcellin | 2009 | Hepatology2009，，4： | 1 |
| 15 | <ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘 | Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick | 2008 | Gastroenterology2008，，2： | 1 |
| 16 | Description of the immature stages of a rare Andean paramo butterfly Lymanopoda caracara Pyrcz, Willmott & J. Hall, 1999(Lepidoptera: Nymphalidae)显示文摘Immature stages of Lymanopoda caracara Pyrcz,Willmott&Hall,an endemic butterfly from the paramo life zone in the Andes of Ecuador,are described and compared with those of L.schmidti Adams from Colombia.Larval morphology is illustrated for four instars.Drawings of head chaetotaxy and setal maps are provided for the first time for the genus.The host plant is identified as a dwarf bamboo Chusquea villosa(Clark)(Poaceae).Striking individual variation among adults of L.caracara is discussed. | Pablo Padron Pierre Boyer Ariana Velez Tomasz Pyrcz | 2019 | Zoological Systematics2019，44，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员